31
Participants
Start Date
December 11, 2000
Primary Completion Date
March 27, 2002
Study Completion Date
March 27, 2002
troxacitabine
Memorial Sloan-Kettering Cancer Center, New York
New York Medical College, Valhalla
Cancer Center of Albany Medical Center, Albany
Duke Comprehensive Cancer Center, Durham
MD Anderson Cancer Center Orlando, Orlando
Northwestern University Medical Center, Chicago
Baylor University Medical Center, Dallas
Cedars-Sinai Comprehensive Cancer Center, Los Angeles
Cancer Center and Beckman Research Institute, City of Hope, Duarte
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
University of Chicago Cancer Research Center, Chicago
Johns Hopkins Oncology Center, Baltimore
University of Pennsylvania Cancer Center, Philadelphia
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia
University of Texas - MD Anderson Cancer Center, Houston
Health Sciences Centre, Winnipeg
Ottawa General Hospital, Ottawa
Princess Margaret Hospital, Toronto
Maisonneuve-Rosemont Hospital, Montreal
Royal Victoria Hospital - Montreal, Montreal
Lead Sponsor
Shire
INDUSTRY